Alice Efuntayo

Alice Efuntayo

Auto-generated profile, based on publicly available information

Alice Efuntayo

Department of Anatomical Sciences, School of Biomedical Sciences, Faculty of Health Sciences, University of the Witwatersrand, Parktown, Johannesburg, Republic of South Africa

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2024 in Cardiovascular Toxicology
Verified
Journal Article
Open access
PDF file
MNMakgotso Nchodu
Makgotso Nchodu
AEAlice Efuntayo
Alice Efuntayo
RPRobin du Preez
Robin du Preez
HAHasiena Ali
Hasiena Ali
OOOladiran Olateju
Oladiran Olateju
Alcohol abuse by adolescents is becoming a serious health concern as they often progress to becoming alcoholics later in life which may lead to heart problems. Chronic alcohol use alters the cardiac function and structure, such as haemodynamic changes, weakening and loss of cardiomyocytes, myocardial fibrosis, and inflammation. Simvastatin is a commonly used drug for the treatment and management of various cardiovascular problems but information on its protective effects against alcohol-induced cardiomyocyte hypertrophy, fibrosis, and inflammation is lacking in the literature. Four-week-old male (n = 5) and female (n = 5) C57BL/6 J mice were assigned to each experimental group: (I) NT—no administration of alcohol or Simvastatin; (II) ALC—2.5 g/Kg/day of 20% alcohol via intraperitoneal injection (i.p.); (III) SIM—5 mg/Kg/day of Simvastatin via oral gavage; (iv) ALC + SIM5—5 mg/Kg/day of Simvastatin via oral gavage followed by 2.5 g/Kg/day of 20% alcohol via i.p.; and (v) ALC + SIM15—15 mg/Kg/day Simvastatin via oral gavage followed by 2.5 g/Kg/day of 20% alcohol via i.p. After the 28-day treatment period, the heart was removed and processed for H&E, Masson’s trichrome, or TNF-α immunolabelling. The area and diameter of cardiomyocytes were measured on the H&E-stained sections. The distribution of collagen or TNF-α expression was quantified using the deconvolution tool of ImageJ software. The results confirmed alcohol-induced toxicity on the cardiomyocytes and Simvastatin reduced alcohol-induced cardiomyocyte hypertrophy, fibrosis, and inflammation in both sexes. This study demonstrated that Simvastatin, an FDA approved and easily accessible drug, may be beneficial in lowering the prevalence of alcohol-induced cardiovascular diseases (especially in adolescents) which will have a huge financial implication on health systems worldwide.

9 July 2025 in Metabolic Brain Disease
Verified
Journal Article
Open access
PDF file
RPRobin du Preez
Robin du Preez
TMTabo Mwila
Tabo Mwila
AEAlice Efuntayo
Alice Efuntayo
OOOladiran Olateju
Oladiran Olateju
Adolescent alcohol abuse in disadvantaged communities is a significant concern due to regulatory gaps. It disrupts brain development, particularly affecting the hippocampus, which is vulnerable to alcohol-induced oxidative stress, resulting in impaired neuronal signalling, increased cell death, and reduced neurogenesis. Simvastatin, a cholesterol-lowering drug, has neuroprotective and antioxidant effects, but its potential in protecting against alcohol-related brain damage is unclear. This study examined the protective effects of Simvastatin in four-week-old C57BL/6J mice administered 20% alcohol (intraperitoneal, i.p.), 5 or 15 mg/kg Simvastatin orally, followed by 20% alcohol (i.p.) or the controls (i.e., 5 mg/kg Simvastatin only or no treatment). After 28 days, the harvested brains underwent biochemical or immunohistochemical (IHC) analysis. Biochemical analyses measured malondialdehyde (MDA) levels, glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activity in homogenised hippocampal samples and IHC involved immunolabelling for PcNA or DCX. PcNA- or DCX-positive cells in the suprapyramidal blade of the dentate gyrus were counted using QuPath software. Alcohol elevated GSH-Px activity, indicating oxidative damage, but both Simvastatin concentrations reduced this, with 15 mg being more effective in females. MDA level and SOD activity remained unchanged. Simvastatin at 5 mg reduced alcohol’s effect on PcNA-positive cells in both sexes, while 15 mg was more effective in females. For DCX-positive cells, 5 mg Simvastatin was protective in both sexes, but 15 mg showed no effect. Overall, Simvastatin exhibited antioxidant and neuroprotective effects against alcohol-induced hippocampal damage, suggesting its potential for treating alcohol-related brain disorders.